Is Iodine-125 Monotherapy Suitable for the Full Spectrum of Intermediate Risk Prostate Cancer?MarkW. James Morris[0]Ross Halperin[0]Mira Keyes[0]Tom Pickles[0]Ingrid Spadinger[0]Brachytherapy, pp. S582018.Cited by: 0|Bibtex|Views3|Code: Data: Full Text (Upload PDF)PPT (Upload PPT)Upload PDFUpload PPTYour rating :0 TagsCommentsSubmit
